Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Japanese companies report cephems

Sep. 6, 1996

NSC-665158: HIV-1 reverse transcriptase inhibitor analogue

Aug. 30, 1996

Antiherpes compounds from Bio-Mega/Boehringer Ingelheim

Aug. 30, 1996

Influenza A virus sialidase inhibitors from Glaxo Wellcome

Aug. 30, 1996

Tetromycin A: a novel antibacterial agent

Aug. 30, 1996

Antifungal agents from Hokko Kagaku

Aug. 30, 1996

Dura obtains marketing rights of Lilly's cephalosporin antibiotics

Aug. 30, 1996

Erythromycin A 9-O-oxime derivatives from Zambon

Aug. 23, 1996

SR-3775: Promising candidate for cytomegalovirus disease treatment

Aug. 23, 1996

GEM-132 enters phase I safety and pharmacokinetic trial

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.